How many doses of Wegovy does it take to lose weight?

You've just started Wegovy, here's what the first few months actually look like

Picture this: your first pen is in the fridge door, weekly injection day circled on your phone calendar, and you're wondering when something will actually happen. That's the most common place people are when they ask this question.

Wegovy begins at 0.25mg once a week for the first four weeks. At this stage, the dose is not intended to produce substantial weight loss. Its job is to introduce semaglutide to your system gently, reducing the chance of nausea and other gastrointestinal discomfort. The 0.5mg step follows for another four weeks, and again the primary purpose is adjustment rather than treatment effect.

From month three onward (at 1.0mg) most people begin to notice a real reduction in appetite. The step to 1.7mg comes around week 13, and the standard maintenance dose of 2.4mg is typically reached around week 17, roughly four months in. Each step up is assessed by your prescriber, who can slow the titration if side effects are a problem. The full Wegovy dose range and what each step involves is worth reviewing before you begin, so you know what to expect at each stage.

If you are also trying to work out how many doses each Wegovy pen contains, that detail is useful for planning your supply before you start. The honest answer to the headline question: most people take around 17 to 20 weekly doses before they reach the dose consistently linked to significant weight reduction. The weight loss itself continues to build from there, over months rather than weeks.

When do most people start to see the weight-loss effect, and how much can they expect?

Weight reduction on Wegovy tends to be gradual and cumulative. Some people notice appetite changes within the first few weeks. A meaningful shift on the scales is more commonly reported once doses of 1.0mg and above are reached, roughly from month three.

The landmark STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks at the 2.4mg maintenance dose alongside lifestyle changes. Average body weight fell by around 15%. That figure is a population average from a controlled trial, individual results vary depending on starting weight, diet, activity, and how consistently someone stays on treatment.

A higher dose option also now exists. The MHRA approved a dedicated 7.2mg single-dose pen in April 2026, for adults with a BMI of 30 or above. Trials at this dose reported average weight loss of around 20.7% over 72 weeks, narrowing the gap with tirzepatide results. Whether this dose is appropriate for you is a clinical decision; understanding what dosage of Wegovy is needed to lose weight can help you have a more informed conversation with your prescriber about where on that path you are. You can read more about how doses compare across the Wegovy dose range.

The programme is not a quick course, it is a long-term treatment designed to work over months. Guidance from NICE recommends considering whether to continue if less than 5% weight loss has occurred after six months on the maintenance dose.

What affects how many doses you need, and what slows progress?

Several things influence how quickly and how far the dose ladder moves. Gastrointestinal side effects (nausea, loose stools, constipation, reflux) are the most common reason a prescriber might pause titration at a particular step rather than advancing on schedule. That is not a failure; it is the dose doing exactly what it should and the prescriber responding sensibly.

Lifestyle factors matter alongside the medicine. Wegovy's appetite-suppressing effect is most effective when paired with a reduced-calorie diet and increased physical activity, as the NHS guidance on semaglutide makes clear. Protein intake, hydration and regular movement all support the process, and your prescriber or a dietitian can advise on the specifics for your situation.

Missing doses occasionally is not catastrophic, but a pattern of missed injections will slow progress and may require restarting at a lower dose depending on how long the gap has been. Questions about specific missed doses should go to your prescriber and the Patient Information Leaflet, not a general content page.

It is also worth knowing that under-18s, people who are pregnant, breastfeeding or trying to conceive are not suitable candidates for Wegovy. If those circumstances change during treatment, contact your prescriber promptly.

How Wegovy is prescribed privately, and what that process looks like at a regulated pharmacy

Wegovy is a prescription-only medicine. The legal route to it in the UK is a consultation followed by a clinical assessment, carried out by a registered prescriber who reviews your medical history, current medications, and weight before deciding whether to prescribe. There is no shortcut to that step.

If you are weighing up the cost of Wegovy privately, it helps to know what that price should include: the consultation, the prescription, the medicine itself, and ongoing clinical oversight. Services that appear to offer Wegovy at unusually low prices, or without asking detailed clinical questions, are a red flag worth taking seriously. The MHRA has seized large quantities of fake weight-loss pens sold online, report anything suspicious via the Yellow Card scheme.

At nume, every consultation is reviewed the same day by a GPhC-registered Independent Prescriber. If clinically appropriate, treatment is dispatched the same day for free next-working-day delivery. You can find out more about how Wegovy works as a treatment or explore the full range of weight-loss options before deciding.

If you are ready to find out whether Wegovy is suitable for you, check your eligibility with our clinical team, no commitment required.